Czechia· CZ-0027234
ACTRAPHANE 30
A insulin (human) product containing insulin human + insulin injection, isophane, registered in Czechia by Novo Nordisk A/S, Bagsvaerd. The same ATC class is registered in 9 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Insulin (human) is registered in 9 of 19 countries.
Countries holding a registration under ATC A10AD01 (insulin (human)), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Insulin (human) · ATC A10AD01
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- INSULIN HUMAN + INSULIN INJECTION, ISOPHANE
- Manufacturer
- Novo Nordisk A/S, Bagsvaerd
- Country
- Czechia (CZ)
- ATC code
- A10AD01
- ATC class
- Insulin (human)
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
461 interactions on record for insulin (human).
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin (human) · interactions on record
461 records
- 15 severe
- 395 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10AD01
Insulin (human), as other registers publish it.
- IrelandActraphaneNovo Nordisk A/S
- FinlandActraphane 10 NovoletNovo Nordisk A/S
- DenmarkActraphane 10 NovoLetNovo Nordisk A/S
- FinlandActraphane 10 PenfillNovo Nordisk A/S
- FinlandActraphane 20 NovoletNovo Nordisk A/S
- DenmarkActraphane 20 NovoLetNovo Nordisk A/S
- FinlandActraphane 20 PenfillNovo Nordisk A/S
- FinlandActraphane 30Novo Nordisk A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3725665-2430-4f50-8b65-56212827f006 GET /v1/drugs/d3725665-2430-4f50-8b65-56212827f006?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SUS VIA",
"source": "sukl",
"strength": "100IU/ML",
"pack_size": "5X(1X10ML)",
"substance": "INSULIN HUMAN + INSULIN INJECTION, ISOPHANE",
"cz_kod_sukl": "0027234",
"product_type": "BT",
"substance_codes": "4960,2349",
"registration_state": "R",
"registration_number": "EU/1/02/229/037"
}See everything about insulin (human).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.